A Drug By Roche, May Cure Early Stage Breast Cancer

The FDA might approve as early as Oct. 31st, a new drug called Perjeta. 

Roche is presently in mid-stage trials and it looks encouraging. The drug Perjeta, might become the first medicine a women might take, before considering breast surgery.

Breast cancer in the United States, is considered the second most deadly cancer. It is expected to kill approximately 39,000 Americans in this year alone. This is according to the National Cancer Society.

To read and find out more information regarding this encouraging drug for breast cancer, called Perjeta, go to this link!